Komori
Nissan Chemical (4021) · PolicyAdvanced

Rationale Verification and Voting Policy for Cross-Shareholdings

First written in FY2017. 5 of 7 entries say "Advanced", first in FY2021. Latest entry: FY2026.

7entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018AdvancedFY2021 – FY20262017: 120172018: 120182019: 020192020: 020202021: 120212022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Verification of the Rationale for Strategic ShareholdingsA theme 1239 companies write about · 1 as a headwind · 659 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1243 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Stocks whose number of shares increased during the fiscal year」

    The company acquired shares in 1 unlisted company to promote research and development while reducing its holdings in 1 other unlisted company. It is implementing its policy of assessing the rationale for holdings.
  2. FY2024AdvancedAnnual report

    「Holdings whose number of shares decreased during the fiscal year」

    During the fiscal year, the company reduced the number of shares held in 5 listed companies and 2 unlisted companies. It added evidence of its annual assessment of holding rationale and implementation of its policy of selling holdings that are not deemed reasonable.
  3. FY2023AdvancedAnnual report

    「Each year, the Board of Directors comprehensively considers the business necessity of maintaining and strengthening transactions and other relationships with investee companies, whether the benefits of holding the shares are commensurate with the cost of capital, and whether the holdings contribute to improving the company's medium- to long-term corporate value. If a holding is not deemed reasonable, the company will sell it while taking into consideration the impact on the market and other relevant circumstances.」

    During the fiscal year, the company reduced the number of shares held in 6 listed companies and 1 unlisted company, demonstrating the implementation of its policy for assessing holding rationale and selling holdings.
  4. FY2022AdvancedAnnual report

    「Holdings whose number of shares decreased during the fiscal year」

    During the fiscal year, the company reduced the number of shares held in 5 listed companies and 2 unlisted companies. It added evidence of implementing its policy of selling holdings that are not deemed reasonable.
  5. FY2021AdvancedAnnual report

    「Each year, the Board of Directors comprehensively considers the business necessity of maintaining and strengthening transactions and other relationships with investee companies, whether the benefits of holding the shares are commensurate with the cost of capital, and whether the holdings contribute to improving the company's medium- to long-term corporate value. If a holding is not deemed reasonable, the company will sell it while taking into consideration the impact on the market and other relevant circumstances.」

    The company added comparison with the cost of capital to its criteria for assessing strategic shareholdings and expressly stated its policy of selling holdings that are not deemed reasonable. In fiscal 2020, it reduced its holdings in 15 listed companies.
  6. FY2018RestatedAnnual report

    「The company holds strategic shareholdings when, after comprehensive consideration, they are deemed reasonable based on the business necessity of maintaining and strengthening transactions and other relationships with investee companies, medium- to long-term economic rationale in light of returns and risks, and whether they contribute to improving the company's medium- to long-term corporate value.」

    The company continues to annually verify the rationale for strategic shareholdings at Board of Directors meetings and determine voting decisions based on medium- to long-term corporate value and other factors.
  7. FY2017First statedAnnual report

    「The company holds strategic shareholdings when, after comprehensive consideration, they are deemed reasonable based on the business necessity of maintaining and strengthening transactions and other relationships with investee companies, medium- to long-term economic rationale in light of returns and risks, and whether they contribute to improving the company's medium- to long-term corporate value. The Board of Directors annually verifies the rationale for holding major strategic shareholdings and confirms whether they should continue to be held.」

    The company determines strategic shareholdings based on business necessity, economic rationale and their contribution to corporate value, and annually verifies the rationale for continued holdings at Board of Directors meetings.
Moved together

"Continuation of research and development activities" moved the same way as this thread, in the same document, in 5 of its 7 moves.

555554★123456
  1. ★This thread
  2. 1Continuation of research and development activities5×
  3. 2Global rollout of the fluralaner product Bravecto and strengthening of the production system5×
  4. 3Domestic and Overseas Registration and Launch of Agrochemical Products and Expansion of Sales Channels5×
  5. 4Investment in manufacturing and research facilities and development of facilities for new products5×
  6. 5Advancing Clinical Development of the Drug Discovery Pipeline and External Partnerships5×
  7. 6Strengthening Transparency, Compliance, Environmental Responsibility and Social Contribution4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nissan Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Rationale Verification and Voting Policy for Cross-Shareholdings | Nissan Chemical Corporation (4021) | Komori